Candida guilliermondii as the aetiology of candidosis

Detalhes bibliográficos
Autor(a) principal: Pasqualotto, Alessandro Comarú
Data de Publicação: 2006
Outros Autores: Antunes, Ana Graciela Ventura, Severo, Luiz Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/30990
Resumo: Candida guilliermondii is one of the components of human microbiota. This yeast has been infrequently associated with human infections, which may be related to its low pathogenicity. The aim of this study was to provide clinical and epidemiological data for patients infected with C. guilliermondii at Santa Casa Complexo Hospitalar, Brazil. From October 1997 to October 2003, C. guilliermondii was isolated from clinical samples from 11 patients. Three patients were excluded because the isolation of the yeast represented colonisation. Specimens from the eight patients included in the study corresponded to blood (n = 5), ascitis fluid (n = 2), and oesophagus biopsy (n = 1). Three patients (37.5%) had major immunosuppressed conditions, including solid organ transplantation, AIDS, and leukaemia. Previous use of antibiotics occurred in 87.5%. Main invasive medical procedures were central venous catheter (50.0%), abdominal surgery (25.0%), and peritoneal dialysis (50.0%). No susceptibility data was obtained. Although risk factors for candidaemia were similar amongst patients infected by with C. guilliermondii or other Candida species, mortality associated with C. guilliermondii was significantly lower.
id IMT-1_c9ac874a6e3b0e708d670377575e5e95
oai_identifier_str oai:revistas.usp.br:article/30990
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling Candida guilliermondii as the aetiology of candidosis Candida guilliermondii como agente de candidose Candida guilliermondiNon-albicans Candida speciesCandidaemiaCandidiasisPeritonitisOesophagitisAIDS Candida guilliermondii is one of the components of human microbiota. This yeast has been infrequently associated with human infections, which may be related to its low pathogenicity. The aim of this study was to provide clinical and epidemiological data for patients infected with C. guilliermondii at Santa Casa Complexo Hospitalar, Brazil. From October 1997 to October 2003, C. guilliermondii was isolated from clinical samples from 11 patients. Three patients were excluded because the isolation of the yeast represented colonisation. Specimens from the eight patients included in the study corresponded to blood (n = 5), ascitis fluid (n = 2), and oesophagus biopsy (n = 1). Three patients (37.5%) had major immunosuppressed conditions, including solid organ transplantation, AIDS, and leukaemia. Previous use of antibiotics occurred in 87.5%. Main invasive medical procedures were central venous catheter (50.0%), abdominal surgery (25.0%), and peritoneal dialysis (50.0%). No susceptibility data was obtained. Although risk factors for candidaemia were similar amongst patients infected by with C. guilliermondii or other Candida species, mortality associated with C. guilliermondii was significantly lower. Candida guilliermondii é um dos componentes da microbiota humana e infecções associadas com esta levedura têm sido incomuns, o que pode ser atribuído a sua baixa patogenicidade. O objetivo deste trabalho foi documentar aspectos clínico-epidemiológicos em pacientes que tiveram C. guilliermondii isolada a partir de amostras biológicas. O estudo foi conduzido na Santa Casa Complexo Hospitalar, Brasil. Durante outubro de 1997 e outubro de 2003, C. guilliermondii foi isolada de 11 pacientes, três dos quais foram excluídos por se apresentarem apenas colonizados. Espécimes clínicos corresponderam a sangue (n = 5), líquido de ascite (n = 2) e biópsia de esôfago (n = 1). Três pacientes eram imunodeprimidos, incluindo transplante de órgãos sólidos, SIDA e leucemia. Uso prévio de antimicrobianos ocorreu em 87,5% dos casos. Procedimentos médicos invasivos incluíram o uso de cateteres venosos centrais (50,0%), cirurgia abdominal (25,0%) e diálise peritonial (50,0%). Testes de susceptibilidade não foram realizados. Embora fatores de risco para candidemia tenham sido semelhantes entre pacientes infectados por C. guilliermondii ou outras espécies de Candida, a mortalidade associada com C. guilliermondii foi significativamente menor. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo2006-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/30990Revista do Instituto de Medicina Tropical de São Paulo; Vol. 48 No. 3 (2006); 123-127 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 48 Núm. 3 (2006); 123-127 Revista do Instituto de Medicina Tropical de São Paulo; v. 48 n. 3 (2006); 123-127 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/30990/32874Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessPasqualotto, Alessandro ComarúAntunes, Ana Graciela VenturaSevero, Luiz Carlos2012-07-07T18:53:23Zoai:revistas.usp.br:article/30990Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:51:42.290478Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv Candida guilliermondii as the aetiology of candidosis
Candida guilliermondii como agente de candidose
title Candida guilliermondii as the aetiology of candidosis
spellingShingle Candida guilliermondii as the aetiology of candidosis
Pasqualotto, Alessandro Comarú
Candida guilliermondi
Non-albicans Candida species
Candidaemia
Candidiasis
Peritonitis
Oesophagitis
AIDS
title_short Candida guilliermondii as the aetiology of candidosis
title_full Candida guilliermondii as the aetiology of candidosis
title_fullStr Candida guilliermondii as the aetiology of candidosis
title_full_unstemmed Candida guilliermondii as the aetiology of candidosis
title_sort Candida guilliermondii as the aetiology of candidosis
author Pasqualotto, Alessandro Comarú
author_facet Pasqualotto, Alessandro Comarú
Antunes, Ana Graciela Ventura
Severo, Luiz Carlos
author_role author
author2 Antunes, Ana Graciela Ventura
Severo, Luiz Carlos
author2_role author
author
dc.contributor.author.fl_str_mv Pasqualotto, Alessandro Comarú
Antunes, Ana Graciela Ventura
Severo, Luiz Carlos
dc.subject.por.fl_str_mv Candida guilliermondi
Non-albicans Candida species
Candidaemia
Candidiasis
Peritonitis
Oesophagitis
AIDS
topic Candida guilliermondi
Non-albicans Candida species
Candidaemia
Candidiasis
Peritonitis
Oesophagitis
AIDS
description Candida guilliermondii is one of the components of human microbiota. This yeast has been infrequently associated with human infections, which may be related to its low pathogenicity. The aim of this study was to provide clinical and epidemiological data for patients infected with C. guilliermondii at Santa Casa Complexo Hospitalar, Brazil. From October 1997 to October 2003, C. guilliermondii was isolated from clinical samples from 11 patients. Three patients were excluded because the isolation of the yeast represented colonisation. Specimens from the eight patients included in the study corresponded to blood (n = 5), ascitis fluid (n = 2), and oesophagus biopsy (n = 1). Three patients (37.5%) had major immunosuppressed conditions, including solid organ transplantation, AIDS, and leukaemia. Previous use of antibiotics occurred in 87.5%. Main invasive medical procedures were central venous catheter (50.0%), abdominal surgery (25.0%), and peritoneal dialysis (50.0%). No susceptibility data was obtained. Although risk factors for candidaemia were similar amongst patients infected by with C. guilliermondii or other Candida species, mortality associated with C. guilliermondii was significantly lower.
publishDate 2006
dc.date.none.fl_str_mv 2006-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/30990
url https://www.revistas.usp.br/rimtsp/article/view/30990
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/30990/32874
dc.rights.driver.fl_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 48 No. 3 (2006); 123-127
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 48 Núm. 3 (2006); 123-127
Revista do Instituto de Medicina Tropical de São Paulo; v. 48 n. 3 (2006); 123-127
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951645703307264